Gufic Biosciences Limited (Gufic) have received approval from National Medical Products Administration (NMPA), China for product PRILOCAINE (API) which is an amide-type local anaesthetic of fast onset and intermediate duration of action. This approval shall help commercialization of the said product in China and explore Chinese market.